Intervention Protocol

You have free access to this content

Vaccines for preventing influenza in multiple sclerosis patients

  1. Carlo Di Pietrantonj1,*,
  2. Alessandro Rivetti1,
  3. Claudia Baiocchi2,
  4. Adnaan Haq3

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 1 JUL 2013

Assessed as up-to-date: 24 MAY 2013

DOI: 10.1002/14651858.CD010603


How to Cite

Di Pietrantonj C, Rivetti A, Baiocchi C, Haq A. Vaccines for preventing influenza in multiple sclerosis patients (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD010603. DOI: 10.1002/14651858.CD010603.

Author Information

  1. 1

    Azienda Sanitaria Locale ASL AL, Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field, Alessandria, Piemonte, Italy

  2. 2

    MS Consumer, Milano, Italy

  3. 3

    St. George's University of London, Medical School, London, UK

*Carlo Di Pietrantonj, Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field, Azienda Sanitaria Locale ASL AL, Via Venezia 6, Alessandria, Piemonte, 15100, Italy. cdipietrantonj@aslal.it.

Publication History

  1. Publication Status: New
  2. Published Online: 1 JUL 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the safety and the effects of influenza vaccines on disease activity in people with multiple sclerosis (MS).